Adeno-associated virus-mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo

Cancer Gene Therapy

Volumn 9, Issue 6, 2002, Pages 513-521

  Shi, Wenyin ^a   Teschendorf, Christian ^a   Muzyczka, Nicholas ^a   Siemann, Dietmar W ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Adeno associated virus; Angiogenesis; Colorectal neoplasms; Endostatin; Gene therapy

Indexed keywords

ADENOVIRUS VECTOR; ANGIOGENESIS INHIBITOR; CD31 ANTIGEN; COMPLEMENTARY DNA; ENDOSTATIN; GENE PRODUCT; VIRUS VECTOR;

ADENOVIRUS; ANGIOGENESIS; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER THERAPY; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE THERAPY; GENE TRANSFER; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

ANIMALS; ANTIGENS, CD31; CELL DIVISION; CELL LINE; CELL MOVEMENT; CELLS, CULTURED; COLLAGEN; COLORECTAL NEOPLASMS; DEPENDOVIRUS; DNA, COMPLEMENTARY; ENDOSTATINS; ENDOTHELIUM, VASCULAR; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MICE; MODELS, GENETIC; NECROSIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; TIME FACTORS;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; ANIMALIA;

EID: 0036275675     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700463     Document Type: Article

References (48)

1. Angiogenesis in cancer, vascular, rheumatoid and other disease
2. Tumor angiogenesis as a predictor of tumor aggressiveness and metastatic potential in squamous cell carcinoma of the head and neck
3. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer
4. Tumoral vascularity as a prognostic factor in cancer
5. The scope of the problem of primary tumor control
6. Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents
7. Angiogenic attack as a therapeutic strategy for cancer
8. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
9. Anti-vascular approaches to solid tumour therapy: Evaluation of combretastatin A4 phosphate
10. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
11. Endostatin induces endothelial cell apoptosis
12. Endostatin: Yeast production, mutants, and antitumor effect in renal cell carcinoma
13. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
14. Endostatin "cell factories" shrink rodent brain tumors
15. Adeno-associated virus and other potential vectors for angiostatin and endostatin gene therapy
16. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases
17. Administration of helper- dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons
18. Use of adeno-associated virus as a general transduction vector for mammalian cells
19. AAV as a viral vector for human gene therapy. Generation of recombinant virus
20. Long-term correction of obesity and diabetes in genetically obese mice by a single intramuscular injection of recombinant adeno-associated virus encoding mouse leptin
21. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector
22. Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors
23. Long-term in vivo cochlear transgene expression mediated by recombinant adeno-associated virus
24. Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy
25. Progress in adeno-associated virus type 2 vector production: Promises and prospects for clinical use
26. Recombinant adeno- associated virus purification using novel methods improves infectious titer and yield
27. Regional differences in the incidence and growth of mouse tumors following intradermal or subcutaneous inoculation
28. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
29. Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis
30. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein
31. Cloning, expression, and in vitro activity of human endostatin
32. Zinc-dependent dimers observed in crystals of human endostatin
33. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice
34. Intra-tumoral administration of naked plasmid DNA encoding mouse endostatin inhibits renal carcinoma growth
35. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene
36. Adenovirus-mediated delivery of antiangiogenic genes as an antitumor approach
37. Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin
38. Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice
39. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adeno-virus vectors
40. Factors influencing the development of an anti-factor IX (FIX) immune response following administration of adeno-associated virus-FIX
41. Adenovirus and adeno-associated virus as vectors for gene therapy
42. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus
43. Recombinant adeno-associated virus for muscle directed gene therapy
44. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector
45. Development of adeno-associated virus vectors for gene therapy of cystic fibrosis
46. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers
47. Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver
48. Adenovirus-mediated human endostatin gene delivery demonstrates strain-specific antitumor activity and acute dose-dependent toxicity in mice